Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses

International Journal of Impotence Research volume 22, pages 9–19 (2010)Cite this article

An Erratum to this article was published on 13 May 2010

Abstract

The prevalence of hypogonadism has been found to be increased in certain chronic illnesses, especially diabetes, hypertension and obesity. Recently, the prevalence of hypogonadism in primary care practices mirrored that in our population of men with erectile dysfunction (ED). In this study, the prevalence of hypogonadism in nearly 1000 men with ED was tabulated, using a retrospective chart review, and analyzed for association with the various contributing medical and psychological factors. The prevalence of hypogonadism was determined in men with a variety of chronic illnesses, and was further characterized by decade. We observed an association between hypertension (P=0.025), tobacco abuse (P=0.0059), sleep apnea (P=0.0001), work stress (P=0.041) and hypogonadism. These data were further analyzed for the odds ratio and confidence interval (Forest plot), which showed strong association for sleep apnea and work stress. We did not observe any significant association between diabetes, atherosclerosis, alcohol abuse, multiple medications, asthma, seizure disorder, anxiety/depression and hypogonadism (P values for Cochran–Mantel–Haenszel general association were 0.48, 0.97, 0.25, 0.69, 0.22, 0.76 and 0.98, respectively). We suggest that a host of chronic illnesses have a high prevalence of secondary hypogonadism. Men who have chronic medical or psychological illnesses should have their testosterone level checked, especially when sexual dysfunction symptoms or signs are present.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Kaufman JM, Vermeulen A . the decline of androgen levels in elderly men and its clinical and therapeutic implications. End Rev 2005; 26: 833–876.

    Article  CAS  Google Scholar 

  2. Seftel AD . Male hypogonadism. Part I: Epidemiology of hypogonadism. Int J Impot Res 2006; 18: 115–120.

    Article  CAS  Google Scholar 

  3. Gray A, Feldman HA, McKinlay JB, Longcope C . Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73: 1016–1025.

    Article  CAS  Google Scholar 

  4. Wespes E, Schulman CC . Male andropause: myth, reality, and treatment. Int J Impot Res 2002; 14 (S1): S93–S98.

    Article  Google Scholar 

  5. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006; 91: 1995–2010.

    Article  CAS  Google Scholar 

  6. Morley JE, Kaiser FE, Perry 3rd HM, Patrick P, Morley PMK, Stauber PM et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46: 410–413.

    Article  CAS  Google Scholar 

  7. Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004; 89: 5920–5926.

    Article  CAS  Google Scholar 

  8. Araujo AB, Gretchen R, Esche MS, Kupelian V, O'Donnell AB, travison TG et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007; 92: 4241–4247.

    Article  CAS  Google Scholar 

  9. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C . Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006; 60: 762–769.

    Article  CAS  Google Scholar 

  10. Makhlouf AA, Mohamed MA, Seftel AD, Neiderberger C . Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction. Int J Impot Res 2008; 20: 157–161.

    Article  CAS  Google Scholar 

  11. Dobs A . testosterone deficiency and supplementation in chronic disease states. Med Clin North Am 2006; 90 (S1): 14–18.

    Google Scholar 

  12. Ding EL, Song Y, Malik VS, Liu S . Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. J Am Med Assoc 2006; 295: 1288–1299.

    Article  CAS  Google Scholar 

  13. Chandel A, Dhinsa S, Topiwala S, Chadhuri A, Dandona P . Testosterone concentration in young patients with diabetes. Diabetes Care 2008; 31: 2013–2017.

    Article  CAS  Google Scholar 

  14. Seftel A . Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis. Int J Impot Res 2006; 18: 223–228.

    Article  CAS  Google Scholar 

  15. Buvat J, Shabsigh R, Guay A, Gooren L, Torres LO, Meulemen E . Chapter 18: Hormones, metabolism, aging, and men's health. In: Porst H, Buvat J (eds). Standard Practice in Sexual Medicine. Blackwell Publishing: Oxford, UK, 2006, pp, 225–286.

    Chapter  Google Scholar 

  16. Handelsman DJ, Zajac JD . Androgen deficiency and replacement therapy in men. Med J Aust 2004; 180: 529–535.

    PubMed  Google Scholar 

  17. Van der Berghe G, de Zegher F, Bouillon R . Acute and chronic illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998; 83: 1827–1834.

    Google Scholar 

  18. Karagiannis A, Harsoulis F . Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005; 152: 501–513.

    Article  CAS  Google Scholar 

  19. Guay AT, Velasquez E, Perez JB . Characterization of patients in a medical endocrine-based center for male sexual dysfunction. Endocr Pract 1999; 5: 314–321.

    Article  CAS  Google Scholar 

  20. Walczak MK, Lokhandwala N, Hodge MB, Guay AT . Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002; 5: 19–24.

    PubMed  Google Scholar 

  21. Guay AT, Jacobson J . The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction. J Sex Med 2007; 4: 1046–1055.

    Article  CAS  Google Scholar 

  22. Seftel AD, Sun P, Swindle R . the prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004; 171: 2341–2345.

    Article  Google Scholar 

  23. Bjornerem A, Straume S, Midtby M, Fonnebo V, Sundsfjord J, Svartberg J et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab 2004; 89: 6039–6047.

    Article  CAS  Google Scholar 

  24. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen T-P, Valkonen V-P et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004; 27: 1036–1041.

    Article  CAS  Google Scholar 

  25. Muller M, Grobbee DF, den Tonkelaar I, Lamberts SW, van der Schouw YT . Endogenous sex hormones and the metabolic syndrome in aging men. J Clin Endocrinol Metab 2005; 90: 2618–2623.

    Article  CAS  Google Scholar 

  26. Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006; 50: 595–604.

    Article  Google Scholar 

  27. Jackson G . The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism. Eur Urol 2006; 50: 426–427.

    Article  Google Scholar 

  28. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005; 90: 2636–2641.

    Article  CAS  Google Scholar 

  29. Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson E-K et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005; 28: 1636–1642.

    Article  CAS  Google Scholar 

  30. Ponholzer A, Temml C, Obermayer R, Wehrberger C, Madersbacher S . Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005; 48: 512–518.

    Article  Google Scholar 

  31. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R . Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005; 2: 40–52.

    Article  Google Scholar 

  32. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates; results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  Google Scholar 

  33. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB . The relationship between depressive symptoms and male erectile dysfunction; cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458–465.

    Article  CAS  Google Scholar 

  34. Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR . in creased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004; 61: 162–167.

    Article  Google Scholar 

  35. Stanworth RD, Kapoor D, CHanner KS, Jones TH . Statin therapy is associated with lower total but not bioavailable of free testosterone in men with type 2 diabetes. Diabetes Care 2009; 32: 541–546.

    Article  CAS  Google Scholar 

  36. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M . Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985; 60: 444–450.

    Article  CAS  Google Scholar 

  37. Vogel AV, Peake GT, Rada RT . Pituitary-testicular axis dysfunction in burned men. J Clin Endocrinol Metab 1985; 60: 658–665.

    Article  CAS  Google Scholar 

  38. Van Thiel DH . Ethanol: its adverse effects upon the hypothalamic-pituitary-gonadal axis. J Lab Clin Med 1983; 101: 21–33.

    CAS  PubMed  Google Scholar 

  39. Lam KSL, Wang C, Yeung RTT, Ma JTC, Ho JHC, Tse VKC et al. Hypothalamic hypopituitarism following cranial irradiation for nasopharyngeal carcinoma. Clin Endocrinol 1986; 24: 643–651.

    Article  CAS  Google Scholar 

  40. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M . Transient hypogonadotropic hypogonadism after head trauma: effects on steroid precursors and correlation with sympathetic nervous system activity. Clin Endocrinol 1986; 25: 265–274.

    Article  CAS  Google Scholar 

  41. Kreuz LE, Rose RM, Jennings JR . Suppression of plasma testosterone levels and psychological stress: a longitudinal study of young men in officer candidate school. Arch Gen Psychiatry 1972; 26: 479–482.

    Article  CAS  Google Scholar 

  42. Opstad PK . Androgenic hormones during prolonged physical stress, sleep, and energy deficiency. J Clin Endocrinol Metab 1992; 74: 1176–1183.

    CAS  PubMed  Google Scholar 

  43. Rose RM, Bourne PG, Poe RO, Mougey EH, Collins DR, Mason JW . Androgen responses to stress. II Excretion of testosterone, epitestosterone, androsterone and etiocholanolone during basic combat training and under threat of attack. Psychosom Med 1969; 31: 418–436.

    Article  CAS  Google Scholar 

  44. MacConnie SE, Barkan A, Lampsan RM, Schork MA, Beitins IZ . Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. N Engl J Med 1986; 315: 411–417.

    Article  CAS  Google Scholar 

  45. Strauss RH, Lanese RR, Malarkey WB . Weight loss in amateur wrestlers and its effect on serum testosterone levels. JAMA 1985; 254: 3337–3338.

    Article  CAS  Google Scholar 

  46. Barron JL, Noakes TD, Levy W, Smith C, Millar RP . Hypothalamic dysfunction in overtrained athletes. J Clin Endocrinol Metab 1985; 60: 803–806.

    Article  CAS  Google Scholar 

  47. Sato Y, Suzuki N, Horita H, Wada H, Shibuya A, Adachi H et al. Effects of long-term psychological stress on sexual behavior and brain catecholamine levels. J Androl 1996; 17: 83–90.

    PubMed  Google Scholar 

  48. Demura R, Suzuki T, Nakamura S, Komatsu H, Odagiri E, Demura H . Effect of immobilization stress on testosterone and inhibin in male rats. J Androl 1989; 10: 210–213.

    Article  CAS  Google Scholar 

  49. Orr TE, Taylor MF, Bhattacharyya AK, Collins DC, Mann DR . Acute immobilization stress disrupts testicular steroidogenesis in adult male rats by inhibiting the activities of 17α-hydroxylase and 17,20-lyasewithout affecting the binding of LH.hCG receptors. J Androl 1994; 15: 302–308.

    CAS  PubMed  Google Scholar 

  50. Richter SD, Schurmeyer TH, Schedlowski M, Hadicke A, tewes U, Schmidt RE et al. Time kinetics of the endocrine response to acute psychological stress. J Clin Endocrinol Metab 1996; 81: 1956–1960.

    CAS  PubMed  Google Scholar 

  51. Guay AT, Jacobson J, Perez JB, Hodge MB, Velasquez E . Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction; who does and does not respond? Int J Impot Res 2003; 15: 156–165.

    Article  CAS  Google Scholar 

  52. Guay AT, Bansal S, Heatley GJ . Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995; 80: 3546–3552.

    CAS  Google Scholar 

  53. Sun P, Cameron A, Seftel A, Shabsigh R, Niederberger C, Guay A . Erectile dysfunction—an observable marker of diabetes mellitus? A large national epidemiological study. J Urol 2006; 176: 1081–1085.

    Article  Google Scholar 

  54. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G et al. Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med 2008; 5: 2454–2463.

    Article  CAS  Google Scholar 

  55. Bolona ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC et al. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82: 20–28.

    Article  CAS  Google Scholar 

  56. Hall SA, Esche GR, Araujo AB, Travison TG, Clark RV, Willaims RE et al. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. J Clin Endocrinol Metab 2008; 93: 3870–3877.

    Article  CAS  Google Scholar 

  57. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB . The relative contributions of aging, health, and lifestyle fafctors to serum testosterone decline in men. J Clin Endocrinol Metab 2007; 92: 549–555.

    Article  CAS  Google Scholar 

  58. Wu FCW, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW et al. The European Male Aging Study Group. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008; 93: 2737–2745.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was solely supported by the Department of Endocrinology, Lahey Clinic, the Department of Urology, Case Western Reserve University and the Department of Urology, Boston University School of Medicine.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Center for Sexual Function, Lahey Clinic Northshore, Peabody, MA, USA

    A Guay

  2. Department of Urology and Reproductive Biology, Case Western Reserve University, Cleveland, OH, USA

    A D Seftel

  3. Departments of Biochemistry and Urology, Boston University School of Medicine, Boston, MA, USA

    A Traish

Authors
  1. A Guay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A D Seftel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Traish
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Guay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guay, A., Seftel, A. & Traish, A. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. Int J Impot Res 22, 9–19 (2010). https://doi.org/10.1038/ijir.2009.46

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2009.46

Keywords

This article is cited by

Search

Advanced search

Quick links